Laura M. Wake, MD
Pathology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine
About Laura M. Wake
Professional Titles
- Co-Director of the Educational Advisory Committee, Johns Hopkins Department of Pathology
- Flow Cytometry Medical Director
- Assistant Director of the Basic Mechanisms of Disease Pathobiology Course
- Program Director of the Johns Hopkins Hematopathology Fellowship Program
Background
Laura Wake, M.D., is a hematopathologist at the Johns Hopkins Hospital, and an Assistant Professor in the Department of Pathology at the Johns Hopkins University School of Medicine.
Dr. Wake's pathology expertise extends to hematology and oncology. She specifically focuses on hematologic cancers and lymphoid malignancies.
Dr. Wake earned her medical degree at the American University of the Caribbean School of Medicine. She completed an anatomic and clinical pathology residency at the University of Nebraska Medical Center and a hematopathology fellowship at the National Institutes of Health/National Cancer Institute.
Dr. Wake is the Medical Director of the Johns Hopkins Hospital Flow Cytometry Laboratory and is the Program Director of the Hematopathology Fellowship at Johns Hopkins.
Dr. Wake has contributed to numerous publications on hematopathology research.
Selected Publications
Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, Arthur DC, Wake L, Pittaluga S, Yuan CM, Stetler-Stevenson M, Soto S, Valdez J, Nierman P, Lotter J, Xi L, Raffeld M, Farooqui M, Albitar M, Wiestner A. "Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia." Blood. 2017 Mar 16;129(11):1469-1479. doi: 10.1182/blood-2016-06-719294. Epub 2017 Jan 3.
Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, Fu K, Greiner TC, Vose JM, Jaffe E, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Armitage JO, Weisenburger DD, Staudt LM, Gascoyne RD, McKeithan TW, Chan WC. "Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma." Blood. 2015 Feb 12;125(7):1137-45. doi: 10.1182/blood-2014-04-566778. Epub 2014 Dec 10.
Mainali NR, Bhatt VR, Kedia S, Krishnamurthy J, Wake LM, Akhtari M. "Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis." J Oncol Pharm Pract. 2014 Oct;20(5):386-92. doi: 10.1177/1078155213504444. Epub 2013 Sep 24. Review.
Talmon G, Wake L, Muirhead D. "Podoplanin and clusterin are reliable markers of nonneoplastic synovium at various sites." Int J Surg Pathol. 2013 Dec;21(6):587-90. doi: 10.1177/1066896913492195. Epub 2013 Jul 1.
Honors
Outstanding Clinical Pathology Award, University of Nebraska Medical Center
Memberships
- Society for Hematopathology,
Member
- American Society of Hematology,
Member
- United States and Canadian Academy of Pathologists,
Member
- American Society of Clinical Pathology,
Member
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
National Institutes of Health
Fellowship, Hematopathology, 2017University of Nebraska Medical Center
Residency, Pathology, 2015American University of the Caribbean School of Medicine
Medical Education, MD, 2010Board Certifications
Hematopathology
American Board of Pathology, 2016Anatomic Pathology
American Board of Pathology, 2015Clinical Pathology
American Board of Pathology, 2015Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)